 |
April 27, 2009 : |
Joint R&D with Morishita Jintan Co., Ltd.
-Development of New Products Based on
Functional Peptides with Antimicrobial Activity- |
|
April 23, 2009 : |
Intellectual Property Report was updated |
|
April 15, 2009 : |
Substance Patent on Dumbbell-Type (Ribbon-Type)
NF-κB Decoy Oligonucleotide Granted in Japan
-Covering a Circular Oligonucleotide Sequence- |
|
March 26, 2009 : |
AnGes Project Adopted to Receive NEDO Support
- Development of Novel Disinfectants with Antibacterial Peptides - |
|
March 2, 2009 : |
AnGes Reached a Broad Agreement with the FDA on the Clinical Trial Designs for Their Phase III Study with Collategene™ |
|
February 16, 2009 : |
Announcement about the progress of Allovectin-7® Phase 3 pivotal trial |
|
February 6, 2009 : |
AnGes MG continues the collaborations of plasmid HGF for Japan market with
Daiichi-Sankyo while the US/Europe marketing rights are returned |
 |
February 4, 2009 : |
Efficacy of NF-κB decoy oligodeoxynucleotides for periodontal disease confirmed in an animal study
-An academic paper published in the scientific journal, Antioxidants & Redox Signaling- |
|
February 2, 2009 : |
GenomIdea, a Subsidiary of AnGes MG, Signs a Licensing Contract for GEN0101 |
|
December 26, 2008 : |
Promotion of the Program Adopted by the Special District for
Development of Advanced Medical Care (Super Special District)
- GenomIdea Conducts Evaluations for the Formulation and
Manufacture of the Active Pharmaceutical Ingredient - |
|
December 10, 2008 : |
Announcement of New Developments
Concerning the Manufacturing of Novel Nucleic-Acid Hybrid Decoy |
|
November 17, 2008 : |
The Efficacy of NF-κB/Ets Ribbon Type Decoy on
Abdominal Aortic Aneurysm Confirmed in Animal Tests
- Announcement by Osaka University at the Annual Scientific Sessions 2008
of the American Heart Association (AHA) - |
|
November 12, 2008 : |
Termination of Joint Development with Alfresa Pharma Corporation |
|
November 12, 2008 : |
New Direction in the Development of NF-κB Decoy Oligodeoxynucleotide for the Treatment of Atopic Dermatitis in Japan |
|
November 4, 2008 : |
Joint R&D by Three Companies into the “Drug-Eluting Balloon Catheter” to Prevent Vascular Restenosis: Efficacy Confirmed in Animal Tests - Results Announced at the 11th Annual Meeting of the Japan Society of Embolus Detection and Treatment -
|
| |
|
|
